Home2659 • HKG
add
Shanghai Bao Pharmaceuticals Co Ltd Class H
Previous close
$74.30
Day range
$74.45 - $78.45
Year range
$56.00 - $78.45
Market cap
25.57B HKD
Avg Volume
505.19K
P/E ratio
-
Dividend yield
-
Primary exchange
HKG
Market news
Financials
Income Statement
Revenue
Net income
| (CNY) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 21.00M | 2,716.23% |
Operating expense | 78.92M | -6.26% |
Net income | -91.55M | -9.45% |
Net profit margin | -436.05 | 96.11% |
Earnings per share | — | — |
EBITDA | -50.14M | 34.22% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CNY) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 454.40M | — |
Total assets | 1.39B | — |
Total liabilities | 499.10M | — |
Total equity | 889.58M | — |
Shares outstanding | 57.61M | — |
Price to book | 4.81 | — |
Return on assets | -10.45% | — |
Return on capital | -12.78% | — |
Cash Flow
Net change in cash
| (CNY) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -91.55M | -9.45% |
Cash from operations | -52.60M | 39.15% |
Cash from investing | -14.91M | 49.77% |
Cash from financing | 32.26M | 41.43% |
Net change in cash | -35.38M | 61.98% |
Free cash flow | -24.16M | — |
About
Founded
2019
Website
Employees
348
